You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Medullary

Showing 1 - 25 of 587
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Detailed Look At What Patients Experience In Medullary Thyroid

Not yet recruiting
  • Medullary Thyroid Cancer
    • San Francisco, California
      Power Life Sciences
    Oct 6, 2023

    Medullary Sponge Kidney Trial in Lyon (Multiparametic MRI)

    Not yet recruiting
    • Medullary Sponge Kidney
    • Multiparametic MRI
    • Lyon, France
      Hôpital Edouard Herriot
    Dec 27, 2022

    Medullary Thyroid Carcinoma, Nodular Goiter Trial in Pilar (Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin

    Completed
    • Medullary Thyroid Carcinoma
    • Nodular Goiter
    • Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin measurement
    • Pilar, Buenos Aires, Argentina
      Hospital Universitario Austral
    Oct 5, 2023

    Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

    Not yet recruiting
    • Medullary Thyroid Cancer
    • +3 more
    • Groningen, Netherlands
      University Medical Centre Groningen
    Sep 8, 2022

    Deep Medullary Veins and Cognitive Dysfunction in Cerebral Small

    Recruiting
    • Cerebral Small Vessel Disease
      • Zigong, Sichuan, China
        Zigong First People's Hospital
      Feb 4, 2023

      Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

      Not yet recruiting
      • Bronchial and Thymic Neuroendocrine Tumour
      • +3 more
      • Lu-177 DOTATATE (Lutathera®)
      • (no location specified)
      Nov 1, 2023

      Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)

      Not yet recruiting
      • Non-Medullary Thyroid Carcinoma
      • Digoxin tablet
      • (no location specified)
      Aug 20, 2022

      Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

      Not yet recruiting
      • Medullary Thyroid Cancer
      • Cordoba, Spain
      • +1 more
      Jan 11, 2023

      Familial Non-medullary Thyroid Cancer

      Recruiting
      • Non-Medullary Thyroid Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 24, 2022

        Diabetes, Diabetes, Type 2, Medullary Thyroid Carcinoma Trial in Morgantown (No treatment given)

        Enrolling by invitation
        • Diabetes
        • +3 more
        • No treatment given
        • Morgantown, West Virginia
          United BioSource, LLC
        Oct 4, 2022

        Kidney Medullary Carcinoma, Loss of INI 1 Protein Expression, Stage III Renal Cell Cancer AJCC v8 Trial in Houston (Ipilimumab,

        Active, not recruiting
        • Kidney Medullary Carcinoma
        • +3 more
        • Ipilimumab
        • Nivolumab
        • Houston, Texas
          M D Anderson Cancer Center
        Sep 22, 2022

        Metastatic Medullary Thyroid Cancer Trial in Philadelphia (single dose of CART-GFRa4 cells, Fludarabine, Cyclophosphamide)

        Recruiting
        • Metastatic Medullary Thyroid Cancer
        • single dose of CART-GFRa4 cells
        • +2 more
        • Philadelphia, Pennsylvania
          University of Pennsylvania
        Sep 16, 2022

        RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

        Not yet recruiting
        • RET-altered Non Small Cell Lung Cancer
        • +3 more
        • Chang chun, Jilin, China
          Jinlin Province Cancer Hosipital
        Dec 21, 2022

        Medullary Colonic Carcinoma

        Completed
        • Medullary Carcinoma of Colon
        • +2 more
          • Limoges, France
            Service de Chirurgie Digestive et Endocrinienne du CHU de Limoge
          Jan 7, 2022

          Pain, Intractable Trial in Nantes (Implantation of the WAVEWRITER ALPHA ™ device)

          Not yet recruiting
          • Pain, Intractable
          • Implantation of the WAVEWRITER ALPHA ™ device
          • Nantes, France
            CHU de Nantes
          May 25, 2022

          Children and Adults With Medullary Thyroid Cancer

          Recruiting
          • Medullary Thyroid Cancer
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Apr 7, 2022

            Surgical Management of Advanced Thyroid Cancer

            Recruiting
            • Thyroid Carcinoma
            • +6 more
            • Thyroidectomy with or without lymphadenectomy or multivisceral resection
            • Rome, Italy
              Fondazione Policlinico Universitario Agostino Gemelli IRCCS
            Mar 31, 2023

            Medullary Thyroid Cancer Trial in China (Anlotinib Hydrochloride Capsule)

            Recruiting
            • Medullary Thyroid Cancer
            • Anlotinib Hydrochloride Capsule
            • Hefei, Anhui, China
            • +18 more
            Apr 14, 2023

            Medullary Thyroid Carcinoma Trial in Angers, Nantes, Saint-Herblain (• TF2 and 68 Ga-IMP-288)

            Completed
            • Medullary Thyroid Carcinoma
            • • TF2 and 68 Ga-IMP-288
            • Angers, France
            • +2 more
            Jul 22, 2022

            Carcinomas, Renal Medullary Carcinoma Trial in Houston (Nivolumab, Relatlimab)

            Not yet recruiting
            • Carcinomas
            • Renal Medullary Carcinoma
            • Houston, Texas
              MD Anderson Cancer Center
            Apr 20, 2022

            Radioactive Iodine on the Immune System in Thyroid Cancer

            Not yet recruiting
            • Thyroid Carcinoma, Nonmedullary
            • Blood drawing
            • Nijmegen, Netherlands
              Radboud University Medical Center
            Aug 13, 2023

            DOTATOC PET/CT for Imaging NET Patients

            Recruiting
            • Neuroendocrine Tumors
            • +15 more
            • 68Ga-DOTATOC PET/CT
            • 18F-FDG PET/CT
            • Vancouver, British Columbia, Canada
              BC Cancer
            Nov 2, 2022

            Medullary Thyroid Cancer Trial (Ponatinib)

            Withdrawn
            • Medullary Thyroid Cancer
            • (no location specified)
            Oct 6, 2021

            Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

            Recruiting
            • Metastatic Kidney Medullary Carcinoma
            • +4 more
            • Houston, Texas
              M D Anderson Cancer Center
            Jan 20, 2023

            Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

            Recruiting
            • Malignant Thyroid Gland Neoplasm
            • +6 more
            • Quality-of-Life Assessment
            • +3 more
            • Ann Arbor, Michigan
            • +1 more
            Jan 24, 2023